Skip to main content
Have a personal or library account? Click to login
Pharmacological, Optical, and Combined Approaches to Myopia Control in Bulgarian Children: A Longitudinal Study Cover

Pharmacological, Optical, and Combined Approaches to Myopia Control in Bulgarian Children: A Longitudinal Study

Open Access
|Jun 2026

References

  1. Liang J, Pu Y, Chen J, et al. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. British Journal of Ophthalmology. 2024; 108(8): 1021-1029.
  2. Li Xiaotong, Li Lihua, Qin Wen, et al. Urban Living Environment and Myopia in Children: A 2-Year Cohort Study of 177,894 Elementary Schoolchildren in Tianjin, China. JAMA Network Open. 2023;6(12):e2346999.
  3. Zhang X, Li Y, Zhang J, et al. Prevalence and temporal trends in myopia and high myopia in Chinese children and adolescents: a systematic review and meta-analysis with projections to 2050. The Lancet Regional Health - Western Pacific. 2025:59:100443.
  4. Moreira-Roscirio A, Lanca C, Grzybowski A. Prevalence of myopia in Europe: a systematic review and meta-analysis of data from 14 countries. The Lancet Regional Health - Europe. 2025;59:101319.
  5. Dragomirova M, Antonova A, Stoykova S, et al. Myopia in Bulgarian school children: prevalence, risk factors, and health care coverage. BMC Ophthalmology. 2022;22(1):248.
  6. Valcheva K, Ivancheva V. Prevalence and control of myopia among children in Pleven, Bulgaria. Trakia Journal of Sciences. 2022;20(2): 152-157.
  7. Vidinova C, Koeva A. Myopia - risk factors, prevalence in Bulgarian schools, and prevention. Acta Medica Bulgarica. 2024;51(4):29-32.
  8. Lee Y, Keel S, Yoon S. Evaluating the effectiveness and scalability of the WHO MyopiaEd digital intervention program in South Korea: a mixed-methods study. JMIR Public Health and Surveillance. 2024;10:e40323. DOI: 10.2196/40323.
  9. Lawrenson JG, Shah R, Huntjens B, et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023;2:CD014758.
  10. Yu Y, Liu J. The effect of 0.01 % atropine and orthokeratology on ocular axial elongation for myopia children: a meta-analysis. Medicine (Baltimore). 2022;101(18):e29191.
  11. Zadnik K, Schulman E, Flitcroft I, et al. Safety and efficacy of 0. 01 % and 0.02% atropine for treatment of childhood myopia: 36-month results from the CHAMP trial. JAMA Ophthalmol. 2023;141(10):1005-1015.
  12. Perez-Flores I, Macias-Murelaga B, Barrario-Barrio J; GTAM Group. Age-related results over 2 years of the Spanish study of atropine 0.01% in childhood myopia progression. Sci Rep. 2023;13(1):16310.
  13. Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2. Ophthalmology. 2020;127(2):168-177.
  14. Aller TA, Liu M, Wildsoet CF. Myopia control with bifocal contact lenses: a randomized clinical trial. Optom Vis Sci. 2016;93(4):344—352.
  15. Ma JX, Tian SW, Liu QP. Effectiveness of peripheral defocus spectacle lenses in slowing myopia progression: a systematic review. Front Pediatr. 2022; 10:952256.
  16. Morgan IG, French AN, Ashby RS, et al. The epidemics of myopia: aetiology and prevention. Prog Retin Eye Res. 2018;62:134-149.
  17. Tang T, Lu Y, Li X, et al. Comparison of the long-term effects of atropine in combination with orthokeratology and defocus lenses. Eye (Lond). 2024;38(9):1660-1667.
  18. Haarman AEG, Enthoven CA, Tideman JWL, et al. The Complications of Myopia: A Review and Meta-Analysis. IOVS. 2020;61(4):49.
  19. Sindal MD, Behera SP, Chaitanya V. Pediatric retinal detachments in eyes with extreme high myopia. Oman J Ophthalmol. 2025; 18(1):40-43.
  20. Guemes-Villahoz N, Talavero-Gonzalez P, et al. Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results. Br J Ophthalmol. 2025;0:1-7.
  21. Dahlmann-Noor A, Jaselsky A, Whiting C et al. Increasing prevalence of myopia in patients undergoing retinal detachment repair: an 11-year service evaluation. Eye. 2024;38:1231-1232.
  22. Ng DS, Chan LK, Lai TY. Myopic macular diseases: a review. Clin Exp Ophthalmol. 2023;51(3):229-242.
  23. Du Y, Meng J, He W, et al. Complications of high myopia: an update from clinical manifestations to underlying mechanisms. Adv Ophthalmol Pract Res. 2024;4(3):156-163.
  24. Chen CW, Yao JY. Evaluation of risk factors for childhood myopia progression: a systematic review. Indian J Ophthalmol. 2024;72(1):2341-2352.
  25. Yu M, Hu Y, Han M, et al. Global risk factor analysis of myopia onset in children: a meta-analysis. PLOS ONE. 2023; 18(9):e0291470.
  26. Fernandez Irigaray L, Torres R, Zanutigh V, et al. Lifestyle and sleep-related behaviours in children with myopia. BMC Ophthalmol. 2025;25:97.
  27. Karim MS, Shukla H, Mishu Nl, et al. Impact of screen time reduction and outdoor activities on myopia. J Biosci Public Health. 2025;1(1):1-12.
  28. Joachimsen L, Farassat N, Bleul T, et al. Side effects of topical atropine 0.05% compared to 0.01%. Int Ophthalmol. 2021;41(6):2001-2008.
  29. Akagun N, Altiparmak UE. Evaluation of Reasons for Discontinuation of Atropine 0.01%. Turk J Ophthalmol. 2025;55(2):61-66.
  30. Wenyan Xu, Xiaoman Li, Jianing Zhang, et al. The Peripheral Defocus Designed Spectacle Lenses Might Increase Astigmatism. Trans Vis Sci Tech. 2025;14(3):8. https://doi.org/10.1167/tvst.14.3.8.
  31. Bullimore MA, Ritchey ER, Shah S, et al. The Risks and Benefits of Myopia Control. Ophthalmology. 2021;128(11):1561-1579. https://doi.org/10.1016/j.ophtha.2021.04.032.
  32. Chia A, Chua WH, Cheung YB, et al. ATOM-2 Study. Ophthalmology. 2012;119(2):347-354.
  33. Yam JC, Jiang Y, Tang SM, et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study. Ophthalmology. 2019;126(1):113-124.
  34. Lam CSY, Tang WC, Tse DY, et al. DIMS spectacle lenses slow myopia progression: a 2-year trial. Br J Ophthalmol. 2020; 104(3):363-368.
  35. Lam CSY, Tang WC, Lee PH, et al. DIMS lens: 3-year followup study. BrJ Ophthalmol. 2022;106(8):1110-1114.
  36. Huang Z, Chen XF, He T, et al. Synergistic effects of DIMS and atropine. Sci Rep. 2022;12:22311.
DOI: https://doi.org/10.2478/amb-2026-0053 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 10 - 15
Submitted on: Nov 1, 2025
Accepted on: Nov 6, 2025
Published on: Jun 16, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 G. Dimitrov, G. Dimitrova, A. Levi, N. Veleva, O. Mladenov, Y. Kaneva, A. Oscar, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.